These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 15902309)

  • 1. Genome-wide expression analysis of therapy-resistant tumors reveals SPARC as a novel target for cancer therapy.
    Tai IT; Dai M; Owen DA; Chen LB
    J Clin Invest; 2005 Jun; 115(6):1492-502. PubMed ID: 15902309
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synergism between vitamin D and secreted protein acidic and rich in cysteine-induced apoptosis and growth inhibition results in increased susceptibility of therapy-resistant colorectal cancer cells to chemotherapy.
    Taghizadeh F; Tang MJ; Tai IT
    Mol Cancer Ther; 2007 Jan; 6(1):309-17. PubMed ID: 17237289
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pemetrexed disodium combined with oxaliplatin, SN38, or 5-fluorouracil, based on the quantitation of drug interactions in human HT29 colon cancer cells.
    Raymond E; Louvet C; Tournigand C; Coudray AM; Faivre S; De Gramont A; Gespach C
    Int J Oncol; 2002 Aug; 21(2):361-7. PubMed ID: 12118332
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A peptide of SPARC interferes with the interaction between caspase8 and Bcl2 to resensitize chemoresistant tumors and enhance their regression in vivo.
    Rahman M; Chan AP; Tang M; Tai IT
    PLoS One; 2011; 6(11):e26390. PubMed ID: 22069448
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gene expression profiling in myelodysplastic syndrome after SPARC overexpression associated with Ara-C.
    Nian Q; Zhang Z; Wei C; Kuang X; Wang X; Wang L
    Oncol Rep; 2015 Oct; 34(4):2072-82. PubMed ID: 26238482
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Integrative genomic analyses of secreted protein acidic and rich in cysteine and its role in cancer prediction.
    Wang B; Chen K; Xu W; Chen D; Tang W; Xia TS
    Mol Med Rep; 2014 Sep; 10(3):1461-8. PubMed ID: 24938427
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Secreted protein acidic and rich in cysteine as a regulator of murine ovarian cancer growth and chemosensitivity.
    Bull Phelps SL; Carbon J; Miller A; Castro-Rivera E; Arnold S; Brekken RA; Lea JS
    Am J Obstet Gynecol; 2009 Feb; 200(2):180.e1-7. PubMed ID: 18992864
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The c-MYC-ABCB5 axis plays a pivotal role in 5-fluorouracil resistance in human colon cancer cells.
    Kugimiya N; Nishimoto A; Hosoyama T; Ueno K; Enoki T; Li TS; Hamano K
    J Cell Mol Med; 2015 Jul; 19(7):1569-81. PubMed ID: 25689483
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antisense oligonucleotide targeted to RIalpha subunit of cAMP-dependent protein kinase (GEM231) enhances therapeutic effectiveness of cancer chemotherapeutic agent irinotecan in nude mice bearing human cancer xenografts: in vivo synergistic activity, pharmacokinetics and host toxicity.
    Wang H; Hang J; Shi Z; Li M; Yu D; Kandimalla ER; Agrawal S; Zhang R
    Int J Oncol; 2002 Jul; 21(1):73-80. PubMed ID: 12063552
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Secreted protein acidic and rich in cysteine-induced cellular senescence in colorectal cancers in response to irinotecan is mediated by P53.
    Chan JM; Ho SH; Tai IT
    Carcinogenesis; 2010 May; 31(5):812-9. PubMed ID: 20164124
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Improved response to nab-paclitaxel compared with cremophor-solubilized paclitaxel is independent of secreted protein acidic and rich in cysteine expression in non-small cell lung cancer.
    Shao H; Tang H; Salavaggione OE; Yu C; Hylander B; Tan W; Repasky E; Adjei AA; Dy GK
    J Thorac Oncol; 2011 Jun; 6(6):998-1005. PubMed ID: 21532503
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Enhanced antitumor activity of 6-hydroxymethylacylfulvene in combination with irinotecan and 5-fluorouracil in the HT29 human colon tumor xenograft model.
    Britten CD; Hilsenbeck SG; Eckhardt SG; Marty J; Mangold G; MacDonald JR; Rowinsky EK; Von Hoff DD; Weitman S
    Cancer Res; 1999 Mar; 59(5):1049-53. PubMed ID: 10070962
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Heterochromatin Protein 1 Binding Protein 3 Expression as a Candidate Marker of Intrinsic 5-Fluorouracil Resistance.
    Hadac JN; Miller DD; Grimes IC; Clipson L; Newton MA; Schelman WR; Halberg RB
    Anticancer Res; 2016 Mar; 36(3):845-52. PubMed ID: 26976970
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Frequent inactivation of SPARC by promoter hypermethylation in colon cancers.
    Yang E; Kang HJ; Koh KH; Rhee H; Kim NK; Kim H
    Int J Cancer; 2007 Aug; 121(3):567-75. PubMed ID: 17397030
    [TBL] [Abstract][Full Text] [Related]  

  • 15. GEM 231, a second-generation antisense agent complementary to protein kinase A RIalpha subunit, potentiates antitumor activity of irinotecan in human colon, pancreas, prostate and lung cancer xenografts.
    Agrawal S; Kandimalla ER; Yu D; Ball R; Lombardi G; Lucas T; Dexter DL; Hollister BA; Chen SF
    Int J Oncol; 2002 Jul; 21(1):65-72. PubMed ID: 12063551
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of irinotecan in combination with 5-fluorouracil or etoposide in xenograft models of colon adenocarcinoma and rhabdomyosarcoma.
    Houghton JA; Cheshire PJ; Hallman JD; Lutz L; Luo X; Li Y; Houghton PJ
    Clin Cancer Res; 1996 Jan; 2(1):107-18. PubMed ID: 9816097
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A novel myokine, secreted protein acidic and rich in cysteine (SPARC), suppresses colon tumorigenesis via regular exercise.
    Aoi W; Naito Y; Takagi T; Tanimura Y; Takanami Y; Kawai Y; Sakuma K; Hang LP; Mizushima K; Hirai Y; Koyama R; Wada S; Higashi A; Kokura S; Ichikawa H; Yoshikawa T
    Gut; 2013 Jun; 62(6):882-9. PubMed ID: 22851666
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of combined therapy with low-dose 5-aza-2'-deoxycytidine and irinotecan on colon cancer cell line HCT-15.
    Ishiguro M; Iida S; Uetake H; Morita S; Makino H; Kato K; Takagi Y; Enomoto M; Sugihara K
    Ann Surg Oncol; 2007 May; 14(5):1752-62. PubMed ID: 17195906
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Apoptosis mediated chemosensitization of tumor cells to 5-fluorouracil on supplementation of fish oil in experimental colon carcinoma.
    Rani I; Sharma B; Kumar S; Kaur S; Agnihotri N
    Tumour Biol; 2017 Mar; 39(3):1010428317695019. PubMed ID: 28349837
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Establishment and gene analysis of an oxaliplatin-resistant colon cancer cell line THC8307/L-OHP.
    Tang H; Liu YJ; Liu M; Li X
    Anticancer Drugs; 2007 Jul; 18(6):633-9. PubMed ID: 17762391
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.